Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Despite being on the market first, Wegovy has been losing ground to Lilly’s competing drug Zepbound. Novo won a skirmish in ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

From a technical perspective, FTAI Aviation (FTAI) is looking like an interesting pick, as it just reached a key level of support. FTAI recently overtook the 20-day moving average, and this suggests a ...

New research from UC Berkeley and UC Davis suggests that knowing when and where dogs get sick can help us know when humans ...